Hommes O - Search Results

1

Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group.

Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, LeLorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P. Rieckmann P, et al. Among authors: hommes o. Mult Scler Relat Disord. 2015 May;4(3):202-18. doi: 10.1016/j.msard.2015.02.005. Epub 2015 Mar 2. Mult Scler Relat Disord. 2015. PMID: 26008937 Free article. Review.

2

Future MS care: a consensus statement of the MS in the 21st Century Steering Group.

Rieckmann P, Boyko A, Centonze D, Coles A, Elovaara I, Havrdová E, Hommes O, Lelorier J, Morrow SA, Oreja-Guevara C, Rijke N, Schippling S. Rieckmann P, et al. Among authors: hommes o. J Neurol. 2013 Feb;260(2):462-9. doi: 10.1007/s00415-012-6656-6. Epub 2012 Aug 31. J Neurol. 2013. PMID: 22936203 Free PMC article.

3

A quality network model for the daily care of multiple sclerosis.

Blumhardt LD, Vermeij BJ, Amato M, Andersen O, Edan G, Fernandez O, Filippi M, Haas J, Hommes OR, Rieckmann P. Blumhardt LD, et al. Among authors: hommes or. Mult Scler. 2000 Aug;6(4):231-6. doi: 10.1177/135245850000600404. Mult Scler. 2000. PMID: 10962543

4

Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future.

Hommes OR, Barkhof F, Jongen PJ, Frequin ST. Hommes OR, et al. Mult Scler. 1996 Jul;1(6):327-8. doi: 10.1177/135245859600100607. Mult Scler. 1996. PMID: 9345410 Review.

5

Results of an international questionnaire on immunosuppressive treatment of multiple sclerosis.

Hommes OR, Weiner HL. Hommes OR, et al. Mult Scler. 2002 Apr;8(2):139-41. doi: 10.1191/1352458502ms791oa. Mult Scler. 2002. PMID: 11990871

6

ESIMS--an ongoing clinical trial in secondary progressive multiple sclerosis.

Hommes OR, Maas-Enriquez M. Hommes OR, et al. Mult Scler. 2000 Oct;6 Suppl 2:S27-32. Mult Scler. 2000. PMID: 11188776 Clinical Trial.

7

Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.

Sandberg-Wollheim M, Hommes OR, Hughes RA, Paty DW, Abdul-Ahad AK. Sandberg-Wollheim M, et al. Among authors: hommes or. Mult Scler. 1995;1 Suppl 1:S48-50. Mult Scler. 1995. PMID: 9345399

8

No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosis.

Petereit HF, Reske D, Pukrop R, Maas-Enriquez M, Japp G, Jongen PJ, Kölmel HW, Merkelbach S, Hartung HP, Heiss WD, Hommes OR. Petereit HF, et al. Among authors: hommes or. Mult Scler. 2006 Feb;12(1):66-71. doi: 10.1191/135248506ms1246oa. Mult Scler. 2006. PMID: 16459721 Clinical Trial.

9

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.

Hommes OR, Sørensen PS, Fazekas F, Enriquez MM, Koelmel HW, Fernandez O, Pozzilli C, O'Connor P. Hommes OR, et al. Among authors: o connor p. Lancet. 2004 Sep 25-Oct 1;364(9440):1149-56. doi: 10.1016/S0140-6736(04)17101-8. Lancet. 2004. PMID: 15451222 Clinical Trial.

10

Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire.

Hommes OR, Weiner HL. Hommes OR, et al. J Neurol Sci. 2004 Aug 15;223(1):65-7. doi: 10.1016/j.jns.2004.04.022. J Neurol Sci. 2004. PMID: 15261563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page